BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16203685)

  • 21. Expression of fas ligand in human hepatoma cell lines: role of hepatitis-B virus X (HBX) in induction of Fas ligand.
    Shin EC; Shin JS; Park JH; Kim H; Kim SJ
    Int J Cancer; 1999 Aug; 82(4):587-91. PubMed ID: 10404075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression.
    Lara-Pezzi E; Gómez-Gaviro MV; Gálvez BG; Mira E; Iñiguez MA; Fresno M; Martínez-A C; Arroyo AG; López-Cabrera M
    J Clin Invest; 2002 Dec; 110(12):1831-8. PubMed ID: 12488433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct.
    Lin Y; Nomura T; Yamashita T; Dorjsuren D; Tang H; Murakami S
    Cancer Res; 1997 Nov; 57(22):5137-42. PubMed ID: 9371515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes.
    Leverkus M; Yaar M; Gilchrest BA
    Exp Cell Res; 1997 May; 232(2):255-62. PubMed ID: 9168800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.
    Kekulé AS; Lauer U; Weiss L; Luber B; Hofschneider PH
    Nature; 1993 Feb; 361(6414):742-5. PubMed ID: 8441471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function.
    Hsieh JL; Wu CL; Lee CH; Shiau AL
    Clin Cancer Res; 2003 Jan; 9(1):338-45. PubMed ID: 12538486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective transcriptional regulations in the human liver cell by hepatitis B viral X protein.
    Han J; Yoo HY; Choi BH; Rho HM
    Biochem Biophys Res Commun; 2000 Jun; 272(2):525-30. PubMed ID: 10833446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines.
    Bergametti F; Prigent S; Luber B; Benoit A; Tiollais P; Sarasin A; Transy C
    Oncogene; 1999 May; 18(18):2860-71. PubMed ID: 10362257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts.
    Schuster R; Gerlich WH; Schaefer S
    Oncogene; 2000 Feb; 19(9):1173-80. PubMed ID: 10713705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus X protein interferes with cell viability through interaction with the p127-kDa UV-damaged DNA-binding protein.
    Lin-Marq N; Bontron S; Leupin O; Strubin M
    Virology; 2001 Sep; 287(2):266-74. PubMed ID: 11531405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells?
    Roskams T; Libbrecht L; Van Damme B; Desmet V
    J Pathol; 2000 Jun; 191(2):150-3. PubMed ID: 10861574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of protooncogene c-jun by the X protein of hepatitis B virus.
    Twu JS; Lai MY; Chen DS; Robinson WS
    Virology; 1993 Jan; 192(1):346-50. PubMed ID: 8390762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas.
    Su Q; Schröder CH; Hofmann WJ; Otto G; Pichlmayr R; Bannasch P
    Hepatology; 1998 Apr; 27(4):1109-20. PubMed ID: 9537452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis.
    Tralhao JG; Roudier J; Morosan S; Giannini C; Tu H; Goulenok C; Carnot F; Zavala F; Joulin V; Kremsdorf D; Bréchot C
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6991-6. PubMed ID: 12011457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional repression of the human p53 gene by hepatitis B viral X protein.
    Lee SG; Rho HM
    Oncogene; 2000 Jan; 19(3):468-71. PubMed ID: 10656696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The localization of FasL mRNA in liver tissues of chronic hepatitis B].
    Hu J; Zhang L; Zhao J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec; 12(4):316-7. PubMed ID: 12526342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunohistochemical study of Fas ligand in liver tissue of chronic hepatitis B virus infection].
    Hu J; Zhang L; Wang H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):64-6. PubMed ID: 12515176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases.
    Jin YM; Yun C; Park C; Wang HJ; Cho H
    J Viral Hepat; 2001 Sep; 8(5):322-30. PubMed ID: 11555189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter.
    Choi M; Lee H; Rho HM
    IUBMB Life; 2002 Jun; 53(6):309-17. PubMed ID: 12625370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus X protein inhibits nucleotide excision repair.
    Jia L; Wang XW; Harris CC
    Int J Cancer; 1999 Mar; 80(6):875-9. PubMed ID: 10074921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.